Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Coronavirus disease - COVID-19 💬 54 genes, 108 drugs (DrugBank) and 105 diseases |
IL6R [1] IL6R 💬Coronavirus disease - COVID-19
|
Tocilizumab Tocilizumab 💬Coronavirus disease - COVID-19
| Tocilizumab | 002 [24] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬1. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2 | Cytokine-cytokine receptor interaction 💬 89 genes, 142 drugs (DrugBank) and 110 diseases |
IL6R [1] IL6R 💬Cytokine-cytokine receptor interaction
|
Tocilizumab Tocilizumab 💬Cytokine-cytokine receptor interaction
| Tocilizumab | 002 [24] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬2. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3 | Hematopoietic cell lineage 💬 53 genes, 95 drugs (DrugBank) and 101 diseases |
IL6R [1] IL6R 💬Hematopoietic cell lineage
|
Tocilizumab Tocilizumab 💬Hematopoietic cell lineage
| Tocilizumab | 002 [24] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬3. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
4 | HIF-1 signaling pathway 💬 26 genes, 56 drugs (DrugBank) and 87 diseases |
IL6R [1] IL6R 💬HIF-1 signaling pathway
|
Tocilizumab Tocilizumab 💬HIF-1 signaling pathway
| Tocilizumab | 002 [24] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬4. HIF-1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
5 | Human cytomegalovirus infection 💬 64 genes, 114 drugs (DrugBank) and 130 diseases |
IL6R [1] IL6R 💬Human cytomegalovirus infection
|
Tocilizumab Tocilizumab 💬Human cytomegalovirus infection
| Tocilizumab | 002 [24] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬5. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
6 | JAK-STAT signaling pathway 💬 61 genes, 113 drugs (DrugBank) and 123 diseases |
IL6R [1] IL6R 💬JAK-STAT signaling pathway
|
Tocilizumab Tocilizumab 💬JAK-STAT signaling pathway
| Tocilizumab | 002 [24] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬6. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
7 | Non-alcoholic fatty liver disease 💬 23 genes, 52 drugs (DrugBank) and 95 diseases |
IL6R [1] IL6R 💬Non-alcoholic fatty liver disease
|
Tocilizumab Tocilizumab 💬Non-alcoholic fatty liver disease
| Tocilizumab | 002 [24] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬7. Non-alcoholic fatty liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
8 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
IL6R [1] IL6R 💬Pathways in cancer
|
Tocilizumab Tocilizumab 💬Pathways in cancer
| Tocilizumab | 002 [24] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬8. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
9 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
IL6R [1] IL6R 💬PI3K-Akt signaling pathway
|
Tocilizumab Tocilizumab 💬PI3K-Akt signaling pathway
| Tocilizumab | 002 [24] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬9. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
10 | Th17 cell differentiation 💬 56 genes, 80 drugs (DrugBank) and 108 diseases |
IL6R [1] IL6R 💬Th17 cell differentiation
|
Tocilizumab Tocilizumab 💬Th17 cell differentiation
| Tocilizumab | 002 [24] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬10. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
11 | Viral protein interaction with cytokine and cytokine receptor 💬 17 genes, 32 drugs (DrugBank) and 68 diseases |
IL6R [1] IL6R 💬Viral protein interaction with cytokine and cytokine receptor
|
Tocilizumab Tocilizumab 💬Viral protein interaction with cytokine and cytokine receptor
| Tocilizumab | 002 [24] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬11. Viral protein interaction with cytokine and cytokine receptor
|
Coronavirus disease - COVID-19
54 genes, 108 drugs (DrugBank) and 105 diseases
Cytokine-cytokine receptor interaction
89 genes, 142 drugs (DrugBank) and 110 diseases
Hematopoietic cell lineage
53 genes, 95 drugs (DrugBank) and 101 diseases
HIF-1 signaling pathway
26 genes, 56 drugs (DrugBank) and 87 diseases
Human cytomegalovirus infection
64 genes, 114 drugs (DrugBank) and 130 diseases
JAK-STAT signaling pathway
61 genes, 113 drugs (DrugBank) and 123 diseases
Non-alcoholic fatty liver disease
23 genes, 52 drugs (DrugBank) and 95 diseases
Pathways in cancer
111 genes, 222 drugs (DrugBank) and 146 diseases
PI3K-Akt signaling pathway
85 genes, 142 drugs (DrugBank) and 131 diseases
Th17 cell differentiation
56 genes, 80 drugs (DrugBank) and 108 diseases
Viral protein interaction with cytokine and cytokine receptor
17 genes, 32 drugs (DrugBank) and 68 diseases